<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Panacea Biotec Limited — News on 6ix</title>
<link>https://6ix.com/company/panacea-biotec-limited</link>
<description>Latest news and press releases for Panacea Biotec Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 24 Sep 2025 22:14:31 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/panacea-biotec-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364ecb78dffbe2df154ab1.webp</url>
<title>Panacea Biotec Limited</title>
<link>https://6ix.com/company/panacea-biotec-limited</link>
</image>
<item>
<title>Press Release Sep 24 2025</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-24-2025-16</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-24-2025-16</guid>
<pubDate>Wed, 24 Sep 2025 22:14:31 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated September 24, 2025, titled " Panacea Biotec Launches India s first 100% toxin-free and safe NikoMom Baby Skin Care ".</description>
</item>
<item>
<title>Press Release Jun 03 2025</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-jun-03-2025-14</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-jun-03-2025-14</guid>
<pubDate>Tue, 03 Jun 2025 15:14:59 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated Jun 03, 2025, titled "Press Release - Inclusion of EmulsiPan adjuvant in the CEPI Adjuvant Library and its foray into commercialisation of its indigenously developed adjuvants".</description>
</item>
<item>
<title>Press Release Sep 12 2024</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-12-2024-19</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-12-2024-19</guid>
<pubDate>Thu, 12 Sep 2024 19:27:50 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated September 12, 2024, titled "DFC Commits US$20 Million Long-Term Loan to Panacea Biotec Limited towards Capacity-Expansion Project for Hexavalent Vaccine EasySix?".</description>
</item>
<item>
<title>Press Release Aug 14 2024</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-aug-14-2024-41</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-aug-14-2024-41</guid>
<pubDate>Wed, 14 Aug 2024 21:20:27 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated August 14, 2024, titled "Initiation of Phase III Clinical Trial of DengiAll by ICMR andPanacea Biotec Limited".</description>
</item>
<item>
<title>Press Release Dec 14 2023</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-dec-14-2023-17</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-dec-14-2023-17</guid>
<pubDate>Thu, 14 Dec 2023 21:03:29 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated December 14, 2023, titled "Panacea Biotec launches EasyFourPol�� in India and receives registration of Valganciclovir Powder for Oral Solution in Germany".</description>
</item>
<item>
<title>Press Release Aug 22 2023</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-aug-22-2023-7</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-aug-22-2023-7</guid>
<pubDate>Tue, 22 Aug 2023 18:53:40 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated August 22, 2023, titled "US delegation led by Ambassador to India, Assistant Secretary forGlobal Affairs, HHS and HHS Health Attach�� visited Panacea Biotec R&D Centre,Developing Novel Tetravalent Dengue Vaccine DengiAll".</description>
</item>
<item>
<title>Press Release Jan 17 2023</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-jan-17-2023-15</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-jan-17-2023-15</guid>
<pubDate>Tue, 17 Jan 2023 16:10:47 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Panacea Biotec donates 125,000 doses of Easyfive-TT (DTwP-HepB-Hib) a fully liquid Pentavalent vaccine to Ministry of Health, Republic of Cuba for use in the National Health System".</description>
</item>
<item>
<title>Press Release Oct 10 2022</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-oct-10-2022-10</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-oct-10-2022-10</guid>
<pubDate>Mon, 10 Oct 2022 21:58:15 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange about press release dated 10-Oct-2022 titled Panacea Biotec receives awards worth US$ 127.30 million (around INR 1,040 Crore) for supply of Pentavalent Vaccine (DTwP-HepB-Hib) from UNICEF & PAHO</description>
</item>
<item>
<title>Press Release Feb 28 2022</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-feb-28-2022-13</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-feb-28-2022-13</guid>
<pubDate>Tue, 01 Mar 2022 00:44:50 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange about press release dated 28-Feb-2022 titled Mankind Pharma acquires Panacea Biotec���s Domestic Pharmaceutical Formulation Brands</description>
</item>
<item>
<title>Press Release Feb 24 2022</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-feb-24-2022-13</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-feb-24-2022-13</guid>
<pubDate>Fri, 25 Feb 2022 00:49:19 GMT</pubDate>
<description>We are delighted to inform that CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the latest award under its $200m programme, launched in March 21, to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other Betacoronaviruses. CEPI will partner with a consortium comprising of the Translational Health Science and Technology Institute (THSTI), an autonomous institute of the Department of Biotechnology, Ministry of Science and </description>
</item>
<item>
<title>Press Release Feb 21 2022</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-feb-21-2022-16</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-feb-21-2022-16</guid>
<pubDate>Mon, 21 Feb 2022 20:31:33 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange about press release dated 21-Feb-2022 titled CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines</description>
</item>
<item>
<title>Press Release Sep 06 2021</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-06-2021-15</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-06-2021-15</guid>
<pubDate>Tue, 07 Sep 2021 02:25:27 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "Panacea Biotec supplies 1st shipment of the second component of Sputnik V vaccine produced in India".</description>
</item>
<item>
<title>Press Release Jul 04 2021</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-jul-04-2021-1</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-jul-04-2021-1</guid>
<pubDate>Sun, 04 Jul 2021 17:48:26 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated July 04, 2021, titled "Receipt of manufacturing license to produce Sputnik V vaccine at Baddi, Himachal Pradesh".</description>
</item>
<item>
<title>Press Release May 24 2021</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-may-24-2021-15</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-may-24-2021-15</guid>
<pubDate>Mon, 24 May 2021 19:12:57 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Press Release - Russian Direct Investment Fund and Panacea Biotec launch the production of Sputnik V in India".</description>
</item>
<item>
<title>Press Release Apr 05 2021</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-apr-05-2021-9</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-apr-05-2021-9</guid>
<pubDate>Mon, 05 Apr 2021 21:44:14 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated April 05, 2021, titled "Russian Direct Investment Fund and Panacea Biotec agree to produce 100 million doses of Sputnik V vaccine in India per year".</description>
</item>
<item>
<title>Press Release Sep 24 2020</title>
<link>https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-24-2020-9</link>
<guid isPermaLink="true">https://6ix.com/company/panacea-biotec-limited/news/press-release-sep-24-2020-9</guid>
<pubDate>Thu, 24 Sep 2020 15:57:55 GMT</pubDate>
<description>Panacea Biotec Limited has informed the Exchange regarding a press release dated September 24, 2020, titled "Press Release - Successful completion of Phase I/II study of its novel, Tetravalent recombinant chimeric Dengue candidate vaccine, DengiAll".</description>
</item>
</channel>
</rss>